- Science
- Global
High-throughput platform helps engineer fast-acting covalent protein drugs
- April 3, 2026 at 5:40 PM
- 5 views
A team led by principal investigators Bobo Dang and Ting Zhou at Westlake University/Westlake Laboratory have developed a high-throughput platform for engineering fast-acting covalent protein therapeutics. Their study, titled "A high-throughput selection system for fast-acting covalent protein drugs" published in Science, opens new avenues for next-generation biologics.
Originally published at Phys.org